XML 20 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)
 3 Months Ended
Mar. 31, 2012
Mar. 31, 2011
Cash flows from operating expenses:    
Net loss $ (463,569) $ (249,621)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation expense 631 499
Interest income on short-term investment (27) 0
Change in fair value of warrant liabilities (10,446) 0
Stock-based compensation 87,263 0
Cancellation of trade liabilities and unpaid interest (23,153) (17,498)
Changes in operating assets and liabilities:    
Accounts receivable (163,189) (318,082)
Costs and estimated earnings in excess of billings on uncompleted contracts (3,942) 0
Inventory (53,230) 279,945
Prepaid expenses and other current assets (1,405) 3,333
Accounts payable and accrued expenses 26,972 122,919
Accrued compensation and related costs 0 (66,068)
Accrued interest, related party 2,044 0
Accrued interest 0 1,017
Related party accounts payable and accrued expenses 9,300 8,326
Billings in excess of costs and estimated earnings on uncompleted contracts 4,275 (1,800)
Deferred revenue 49,261 194,218
Net cash used in operating activities (539,215) (42,812)
Cash flows used in investing activities    
Purchase of equipment 0 (2,911)
Net cash used in investing activities 0 (2,911)
Cash flows from financing activities:    
Proceeds from issuances of common stock 0 1,000,000
Proceeds from issuance of common stock and warrants in private offering 433,608 0
Net cash provided by financing activities 433,608 1,000,000
Effect of exchange rate changes on cash (27) 0
Net increase (decrease) in cash (105,634) 954,277
Cash and cash equivalents - beginning of period 561,759 1,038,661
Cash and cash equivalents - end of period 456,125 1,992,938
Supplemental disclosure of cash flow information:    
Interest 0 0
Supplemental disclosure of non-cash financing activities:    
In connection with the private offering, $50,000 was paid for a prior liability which was included in accounts payable and accrued expenses.